药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Palbociclib.
Tasosartan
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Palbociclib.
Tasosartan
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Palbociclib.
Tasosartan
Roflumilast
Roflumilast may increase the immunosuppressive activities of Palbociclib.
Tasosartan
Bleselumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Bleselumab.
Tasosartan
Rozanolixizumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Rozanolixizumab.
Tasosartan
Risankizumab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Risankizumab.
Tasosartan
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Palbociclib is combined with Monomethyl fumarate.
Tasosartan
Tetrandrine
The risk or severity of adverse effects can be increased when Palbociclib is combined with Tetrandrine.
Tasosartan
Fluclorolone
The risk or severity of adverse effects can be increased when Palbociclib is combined with Fluclorolone.
Tasosartan
Fluperolone
The risk or severity of adverse effects can be increased when Palbociclib is combined with Fluperolone.
Tasosartan
Begelomab
The risk or severity of adverse effects can be increased when Palbociclib is combined with Begelomab.
Tasosartan
Fluocortin
The risk or severity of adverse effects can be increased when Palbociclib is combined with Fluocortin.
Tasosartan
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Palbociclib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Tasosartan
Hypericin
The risk or severity of adverse effects can be increased when Palbociclib is combined with Hypericin.
Tasosartan
Acteoside
The risk or severity of adverse effects can be increased when Palbociclib is combined with Acteoside.
Tasosartan
Deoxyspergualin
The risk or severity of adverse effects can be increased when Palbociclib is combined with Deoxyspergualin.
Tasosartan
Doxifluridine
The risk or severity of adverse effects can be increased when Palbociclib is combined with Doxifluridine.
Tasosartan
Trofosfamide
The risk or severity of adverse effects can be increased when Palbociclib is combined with Trofosfamide.
Tasosartan
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Palbociclib is combined with Cepeginterferon alfa-2B.